With the prevalence of drug shortages on the rise, the International Society for Pharmaceutical Engineering (ISPE) has stepped in to offer a helping hand by developing the Drug Shortages Prevention Plan (DSPP). The plan is based on a drug shortages survey performed in 2013, which pointed to several key factors to avoid shortages, including developing quality systems and strong management controls. Often, drug shortages are attributed to an excessive number of recalls, unavailable materials or poor product quality, but ISPE asserts the issue usually runs deeper than that, and relates to a company’s overall system of capabilities, controls and culture. Regional economic issues also play a part, but the ISPE plan focuses on what companies can do internally to prevent drug shortages.

“We are developing a Gap Analysis Tool to succinctly analyze – case by case – the risk of drug shortage causes, to aid in the development of mitigation plans,” says François Sallans, Chair of the ISPE Drug Shortages Task Team. Avoiding drug shortages is a complex task and even companies that have a prevention plan in place can fall victim to shortages if they don’t cover all the bases.
Sallans explains, “The ISPE Drug Shortages Prevention Plan is organized around a ‘six dimension’ framework:
- Corporate Quality Culture
- Robust Quality System
- Metrics
- Business Continuity Planning
- Communication with Authorities
- Building Capacity